• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

如今,我们在类风湿关节炎中的治疗目标应该是什么?

What should be our treatment goal in rheumatoid arthritis today?

作者信息

Smolen J S, Aletaha D

机构信息

Department of Rheumatology, Medical University of Vienna; Second Department of Medicine, Lainz Hospital, Vienna, Austria.

出版信息

Clin Exp Rheumatol. 2006 Nov-Dec;24(6 Suppl 43):S-7-13.

PMID:17083756
Abstract

Remission should be the treatment aim in management of rheumatoid arthritis (RA) today because joint damage may progress in RA patients with low disease activity but presumably does not progress in patients in clinical remission. However, stringent criteria are needed to define remission status, as some criteria in current use allow for considerable residual disease activity. Even using stringent criteria, remission is achievable in a sizable proportion of patients in clinical trials and practice. Defining remission requires an additional consideration: Should a patient who is receiving medication be regarded as in remission if disease is absent, or must the patient be off treatment to be considered to be in remission? A case is made for aiming for a definition of remission that includes patients who continue medication therapy.

摘要

如今,缓解应成为类风湿关节炎(RA)治疗的目标,因为疾病活动度低的RA患者关节损伤仍可能进展,但临床缓解的患者关节损伤大概不会进展。然而,需要严格的标准来定义缓解状态,因为目前使用的一些标准仍允许存在相当程度的残余疾病活动度。即便使用严格的标准,在临床试验和实际临床中,仍有相当一部分患者能够实现缓解。定义缓解还需要额外考虑一点:正在接受药物治疗的患者,若没有疾病表现,是否应被视为处于缓解状态,还是必须停药才能被视为处于缓解状态?本文支持将正在接受药物治疗的患者纳入缓解定义范围的观点。

相似文献

1
What should be our treatment goal in rheumatoid arthritis today?如今,我们在类风湿关节炎中的治疗目标应该是什么?
Clin Exp Rheumatol. 2006 Nov-Dec;24(6 Suppl 43):S-7-13.
2
American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.美国风湿病学会/欧洲抗风湿病联盟类风湿关节炎临床试验缓解的临时定义。
Ann Rheum Dis. 2011 Mar;70(3):404-13. doi: 10.1136/ard.2011.149765.
3
ACR remission criteria and response criteria.美国风湿病学会缓解标准和反应标准。
Clin Exp Rheumatol. 2006 Nov-Dec;24(6 Suppl 43):S-14-21.
4
American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.美国风湿病学会/欧洲抗风湿病联盟关于类风湿关节炎临床试验缓解的临时定义
Arthritis Rheum. 2011 Mar;63(3):573-86. doi: 10.1002/art.30129.
5
Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement.类风湿关节炎患者的足部活动性滑膜炎:应用疾病活动度和缓解的临床标准可能会导致对足部关节受累情况的低估。
Arthritis Rheum. 2012 May;64(5):1316-22. doi: 10.1002/art.33506.
6
Remission in rheumatoid arthritis: wishful thinking or clinical reality?类风湿关节炎的缓解:一厢情愿还是临床现实?
Semin Arthritis Rheum. 2005 Dec;35(3):185-96. doi: 10.1016/j.semarthrit.2005.06.003.
7
Modern treatment strategies in rheumatoid arthritis.类风湿关节炎的现代治疗策略
Dan Med Bull. 2011 Nov;58(11):B4320.
8
Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study.在极早期类风湿关节炎中实施达标治疗策略:荷兰类风湿关节炎监测缓解诱导队列研究结果
Arthritis Rheum. 2011 Oct;63(10):2865-72. doi: 10.1002/art.30494.
9
Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis.类风湿关节炎中九个综合指标与关节损伤及身体功能的相关性和 2011 年 ACR/EULAR 缓解标准。
Ann Rheum Dis. 2011 Oct;70(10):1815-21. doi: 10.1136/ard.2010.149260. Epub 2011 Aug 3.
10
Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression.使用改善病情抗风湿药后达到临床缓解的类风湿关节炎患者存在明显滑膜炎:一项影像学研究的证据或许能解释结构进展情况。
Arthritis Rheum. 2006 Dec;54(12):3761-73. doi: 10.1002/art.22190.

引用本文的文献

1
Development of machine learning models for predicting non-remission in early RA highlights the robust predictive importance of the RAID score-evidence from the ARCTIC study.用于预测早期类风湿关节炎(RA)未缓解情况的机器学习模型的开发凸显了RAID评分强大的预测重要性——来自北极研究的证据。
Front Med (Lausanne). 2025 Feb 12;12:1526708. doi: 10.3389/fmed.2025.1526708. eCollection 2025.
2
Identification of SNPs associated with methotrexate treatment outcomes in patients with early rheumatoid arthritis.早期类风湿关节炎患者中与甲氨蝶呤治疗效果相关的单核苷酸多态性的鉴定。
Front Pharmacol. 2022 Nov 17;13:1075603. doi: 10.3389/fphar.2022.1075603. eCollection 2022.
3
Treatment Satisfaction, Patient Preferences, and the Impact of Suboptimal Disease Control in a Large International Rheumatoid Arthritis Cohort: SENSE Study.
大型国际类风湿关节炎队列中的治疗满意度、患者偏好及疾病控制欠佳的影响:SENSE研究
Patient Prefer Adherence. 2021 Feb 17;15:359-373. doi: 10.2147/PPA.S289692. eCollection 2021.
4
A Network Meta-Analysis to Compare Effectiveness of Baricitinib and Other Treatments in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate.一项网状Meta分析,比较巴瑞替尼与其他治疗方法对甲氨蝶呤反应不足的类风湿关节炎患者的有效性。
J Health Econ Outcomes Res. 2020 Apr 10;7(1):10-23. doi: 10.36469/jheor.2020.12273. eCollection 2020.
5
A Multistakeholder Approach to Improving Quality in Rheumatoid Arthritis: Proceedings from the Rheumatoid Arthritis Quality Expert Medical Panel.一种改善类风湿关节炎质量的多利益相关方方法:类风湿关节炎质量专家医学小组会议记录
Am Health Drug Benefits. 2014 Nov;7(8 Suppl 4):S51-61.
6
Radiographic quantifications of joint space narrowing progression by computer-based approach using temporal subtraction in rheumatoid wrist.基于计算机的时间相减方法对类风湿性腕关节关节间隙狭窄进展的影像学定量分析。
Br J Radiol. 2016;89(1057):20150403. doi: 10.1259/bjr.20150403. Epub 2015 Oct 20.
7
Physical function continues to improve when clinical remission is sustained in rheumatoid arthritis patients.类风湿关节炎患者持续临床缓解时,身体功能会持续改善。
Arthritis Res Ther. 2015 Aug 11;17(1):203. doi: 10.1186/s13075-015-0719-x.
8
Variation at FCGR2A and functionally related genes is associated with the response to anti-TNF therapy in rheumatoid arthritis.FCGR2A及功能相关基因的变异与类风湿关节炎患者对抗肿瘤坏死因子治疗的反应相关。
PLoS One. 2015 Apr 7;10(4):e0122088. doi: 10.1371/journal.pone.0122088. eCollection 2015.
9
Pharmacokinetics, efficacy and safety profiles of etanercept monotherapy in Japanese patients with rheumatoid arthritis: review of seven clinical trials.依那西普单药治疗日本类风湿关节炎患者的药代动力学、疗效及安全性概况:七项临床试验综述
Mod Rheumatol. 2015 Mar;25(2):173-86. doi: 10.3109/14397595.2014.914014. Epub 2014 May 20.
10
Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor-α, in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human study.马伏鲁单抗,一种靶向 GM-CSF 受体-α 的人源单克隆抗体,用于类风湿关节炎患者:一项随机、双盲、安慰剂对照、I 期、首次人体研究。
Ann Rheum Dis. 2011 Sep;70(9):1542-9. doi: 10.1136/ard.2010.146225. Epub 2011 May 25.